Toggle light / dark theme

The Role of Artificial Intelligence in Early Cancer Diagnosis

Diagnosing cancer at an early stage increases the chance of performing effective treatment in many tumour groups. Key approaches include screening patients who are at risk but have no symptoms, and rapidly and appropriately investigating those who do. Machine learning, whereby computers learn complex data patterns to make predictions, has the potential to revolutionise early cancer diagnosis. Here, we provide an overview of how such algorithms can assist doctors through analyses of routine health records, medical images, biopsy samples and blood tests to improve risk stratification and early diagnosis. Such tools will be increasingly utilised in the coming years.

Scientists Discover Food Molecules That Trick Cells Into Staying Young

Researchers at the University of Basel in Switzerland have discovered that certain nutrients in food can cause a mild stress reaction in nematodes. Surprisingly, rather than harming the organisms, this slight stress appears to boost their overall health and help them maintain vitality as they grow o

Genetically encoded biosensor tracks plants’ immune hormone in real time

From willow bark remedies to aspirin tablets, salicylic acid has long been part of human health. It also lies at the heart of how plants fight disease. Now, researchers at the University of Cambridge have developed a pioneering biosensor that allows scientists to watch, for the first time, how plants deploy this critical immune hormone in their battle against pathogens.

Published in Science, Dr. Alexander Jones’s group at the Sainsbury Laboratory, Cambridge University (SLCU) presents SalicS1, a genetically encoded biosensor that can detect and track the dynamics of the plant immune hormone (SA) with exquisite precision inside living plants.

Salicylic acid is a central regulator of plant immunity, triggering defense responses against a huge diversity of invaders. Until now, however, scientists have lacked the tools to measure SA at high enough spatial and to understand how plants balance growth with immune defense.

Research highlights solutions to critical gaps in dementia and childhood cancer care

In the United States, significant numbers of adults with dementia require long-term care services. For example, around 750,000 people who live in nursing homes have a diagnosis of dementia. However, transportation insecurity for this population has not received sufficient attention. Although long-term care facilities provide basic medical services, residents with dementia often need external, preventative, and follow-up care such as specialist visits, diagnostics, and dental or vision services. Without reliable nonemergency medical transportation, these needs may go unmet.

To demonstrate the extent of this problem, Postdoctoral Research Scientist Soojeong Han, Ph.D., and her colleagues reviewed existing literature on non-emergency medical for individuals with living in long-term care (LTC) facilities. The study, “Transportation Services in Society for Individuals Living With Dementia in Long-Term Care Facilities: A Scoping Review,” was published in the Journal of the American Medical Directors Association.

Their review found only five publications that mentioned this topic, and even then, only briefly. Across these studies, caregivers, health care professionals, and people with dementia consistently described nonemergency medical transportation as a critical need. Reported barriers included financial strain, rural-urban disparities, lack of continuity among transportation vendors, and dementia-specific challenges such as , stigma, and the need for caregiver accompaniment.

Our Future in Imaging Comes Into Focus

Pushing the bounds of imaging isn’t new for the San Francisco Biohub and Imaging Institute. Both organizations have already taken down barriers to research by building imaging tools that don’t exist anywhere else, as well as creating pioneering cell atlases that have redefined how we understand health and disease.

One example is the San Francisco Biohub’s research on how zebrafish embryos develop over time. In order to capture video images of whole zebrafish embryos through various developmental stages, Biohub scientists built a custom microscope, along with novel software that can find and track the movement of each cell in the videos. The “Google Earth” of embryology resulting from this research is Zebrahub, which brings a new vision to developmental biology and helps us understand our own cellular origins.

Projects like Zebrahub require scientists from a host of different disciplines. Teams across the Biohub, along with interdisciplinary partners, worked to build the microscope, develop the cell tracking software and interpret the resulting images. The collaborative nature of this project isn’t unique to our research on zebrafish — it’s part of our philosophy, and we believe collaboration is critical to drive scientific advancement in all of our work.

Bird flu persists in raw milk cheese, study demonstrates

Raw milk cheese products contained infectious avian influenza virus when made with contaminated raw milk, creating potential health risks for consumers, according to a new study.

At the same time, no virus was detected in test samples of highly acidic raw milk cheese. Feta cheese is an example of a more acidic variety.

The study is published in Nature Medicine.

Scientists are collecting toenail clippings to reveal radon exposure and lung cancer risk

At 47 years of age, Emi Bossio was feeling good about where she was. She had a successful law practice, two growing children and good health. Then she developed a nagging cough. The diagnosis to come would take her breath away.

“I never smoked, never. I ate nutritiously and stayed fit. I thought to myself, I can’t have lung cancer,” says Bossio. “It was super shocking. A cataclysmic moment. There are no words to describe it.”

Bossio had to give up her law practice to focus on treatment and healing. As part of that journey, she’s taken on a new role as an advocate to increase awareness about lung cancer. She still has no idea what caused her lung cancer. Trying to answer that question is how Bossio became interested in the research Dr. Aaron Goodarzi, Ph.D., is doing at the University of Calgary.

1,000-year-old gut microbiome revealed for young man who lived in pre-Hispanic Mexico

Analysis of preserved feces and intestinal tissue has revealed specific types of bacteria that were present in the microbiome of a young adult man who lived in Mexico about 1,000 years ago, prior to Spanish colonization. Santiago Rosas-Plaza of Universidad Nacional Autónoma de México and colleagues present these findings in PLOS One.

The consists of microorganisms, including , that naturally live in people’s intestines. Certain types of bacteria are widely associated with the human gut microbiome, but a person’s particular mix of bacteria may vary depending on factors such as age, diet, health, and where they live. Studying ancient microbiomes using mummies and can therefore deepen understanding of ancient populations and show how the human microbiome may have changed over time.

A growing number of ancient microbiomes have been revealed, including for an ancient Incan person and Germany’s “Tyrolean Iceman.” To further expand the field, Rosas-Plaza and colleagues analyzed the exceptionally well-preserved remains of a man discovered in a in Zimapán, Mexico. Prior analyses suggest the “Zimapán man” was most likely a seasonal seminomadic hunter-gatherer who was part of the ancient Mesoamerican Otopame culture and died about 1,000 years ago between the ages of 21 and 35.

‘Traffic controller’ protein that protects DNA discovered, and it may help kill cancer cells

Mayo Clinic researchers have identified a protein that acts like a traffic controller for DNA, preventing damage during cell division—a discovery that could lead to new cancer therapies, according to a study published in Nature.

“DNA is the code of life. It’s critical for how a cell functions, but it’s also critical for our own being and defines what we are,” says Zhenkun Lou, Ph.D., the Swanson/Schmucker Endowed Professor to Support Health and Cancer Research at Mayo Clinic and the senior author of the new study.

When cells divide, DNA must be copied from one cell to the next—a process called replication. Dr. Lou’s research team discovered that a protein called KCTD10 plays a surprising role in protecting DNA during this critical stage. Acting like a built-in sensor, KCTD10 helps shield the DNA replication from damage.

/* */